Paul Calabresi

3.8k total citations · 1 hit paper
105 papers, 3.1k citations indexed

About

Paul Calabresi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Paul Calabresi has authored 105 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 29 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Paul Calabresi's work include Biochemical and Molecular Research (15 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Treatment and Pharmacology (9 papers). Paul Calabresi is often cited by papers focused on Biochemical and Molecular Research (15 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Treatment and Pharmacology (9 papers). Paul Calabresi collaborates with scholars based in United States, Ireland and United Kingdom. Paul Calabresi's co-authors include Daniel L. Dexter, J A Barbosa, Charles J. McDonald, Walter H. Abelmann, Stephen R. Kaplan, Ronald C. DeConti, William A. Creasey, Arnold D. Welch, Gloria H. Heppner and James W. Darnowski and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Paul Calabresi

102 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells.

1979 239 citations Daniel L. Dexter, Paul Calabresi et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Calabresi United States	31	1.3k	885	489	445	390	105	3.1k
F. M. Schabel United States	22	1.1k 0.8×	1.2k 1.3×	438 0.9×	365 0.8×	463 1.2×	59	2.9k
E.H. Cooper United Kingdom	40	1.2k 0.9×	1.1k 1.2×	426 0.9×	779 1.8×	511 1.3×	146	4.1k
Susan L. Kelley United States	17	1.3k 1.0×	888 1.0×	315 0.6×	281 0.6×	642 1.6×	26	3.4k
S. E. Salmon United States	33	1.7k 1.3×	1.9k 2.1×	365 0.7×	424 1.0×	462 1.2×	78	3.9k
John J. Rinehart United States	27	1.0k 0.8×	988 1.1×	234 0.5×	461 1.0×	568 1.5×	67	2.9k
Robert L. Capizzi United States	37	1.3k 1.0×	1.2k 1.4×	378 0.8×	630 1.4×	143 0.4×	134	4.0k
Stanley P. Balcerzak United States	33	1.2k 0.9×	1.1k 1.2×	193 0.4×	535 1.2×	398 1.0×	105	3.7k
Bayard Clarkson United States	22	1.5k 1.2×	1.8k 2.0×	245 0.5×	524 1.2×	538 1.4×	43	4.9k
Joseph H. Burchenal United States	34	1.3k 1.0×	1.3k 1.5×	219 0.4×	325 0.7×	262 0.7×	147	4.3k
Irwin H. Krakoff United States	32	1.5k 1.1×	1.7k 1.9×	230 0.5×	796 1.8×	200 0.5×	124	4.5k

Countries citing papers authored by Paul Calabresi

Since Specialization

Citations

This map shows the geographic impact of Paul Calabresi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Calabresi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Calabresi more than expected).

Fields of papers citing papers by Paul Calabresi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Calabresi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Calabresi. The network helps show where Paul Calabresi may publish in the future.

Co-authorship network of co-authors of Paul Calabresi

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Calabresi. A scholar is included among the top collaborators of Paul Calabresi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Calabresi. Paul Calabresi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calabresi, Paul, et al.. (2004). Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice. Cancer Chemotherapy and Pharmacology. 53(3). 261–266. 25 indexed citations

Calabresi, Paul, et al.. (2000). Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line. Leukemia Research. 24(6). 519–525. 20 indexed citations

King, Nicholas M. P., Joseph C. Alper, Michael C. Wiemann, Charles J. McDonald, & Paul Calabresi. (1989). Oral 5-Fluorouracil in Psoriasis: Pharmacokinetic-Pharmacodynamic Relationships. Pharmacology. 39(2). 78–88. 16 indexed citations

Calabresi, Paul, et al.. (1988). Basic principles and clinical management of cancer. 7 indexed citations

Spremulli, Ellen N., et al.. (1984). Tissue Analysis of N-Methylformamide: Organ Distribution. Journal of Analytical Toxicology. 8(3). 146–148. 1 indexed citations

Chu, Ming, Fardos N.M. Naguib, Max H. Iltzsch, et al.. (1984). Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine.. PubMed. 44(5). 1852–6. 64 indexed citations

Spremulli, Ellen N., John T. Leith, D. Campbell, et al.. (1983). Response of a human colon adenocarcinoma (DLD-1) to X irradiation and mitomycin C in vivo. International Journal of Radiation Oncology*Biology*Physics. 9(8). 1209–1212. 14 indexed citations

Panzica, Raymond P., et al.. (1982). Synthesis and biological evaluation of certain 4‐alkylamino and 4‐arylalkylamino derivatives of the imidazo[4,5‐d]pyridazine and v‐triazolo[4,5‐d]pyridazine ring systems. Journal of Heterocyclic Chemistry. 19(2). 285–288. 4 indexed citations

Brenner, Harold J., John T. Leith, J. Keith DeWyngaert, et al.. (1981). Protection against Hyperthermic Cell Killing of Mouse Mammary Adenocarcinoma Cells in Vitro by N,N-Dimethylformamide. Radiation Research. 88(2). 291–291. 6 indexed citations

10.

Scholar, Eric & Paul Calabresi. (1979). Increased activity of alkaline phosphatase in leukemic cells from patients resistant to thiopurines. Biochemical Pharmacology. 28(3). 445–446. 12 indexed citations

11.

Diamond, Israel, et al.. (1977). Ultrastructure of myeloma cells in a case with crystalcryoglobulinemia. Cancer. 39(4). 1475–1481. 23 indexed citations

12.

Leitman, Susan F., et al.. (1976). Stimulatory effects of 5-lodo-2'-deoxyuridine on number and function of splenic B- and T-cells and of macrophages in C3HeB/FeJ mice.. PubMed. 36(1). 73–6. 1 indexed citations

13.

DeConti, Ronald C., Stephen R. Kaplan, & Paul Calabresi. (1972). Endotoxin Stimulation in Patients With Lymphoma: Correlation With the Myelosuppressive Effects of Alkylating Agents. Blood. 39(5). 602–609. 5 indexed citations

14.

Mitchell, Malcolm S., Joseph R. Bove, & Paul Calabresi. (1969). SIMPLIFIED ESTIMATION OF MOUSE ISOHEMAGGLUTININS BY MICROASSAY. Transplantation. 7(4). 294–296. 3 indexed citations

15.

Papac, Rose J. & Paul Calabresi. (1966). Infusion of floxuridine in the treatment of solid tumors.. PubMed. 197(4). 237–41. 3 indexed citations

16.

DeConti, Ronald C. & Paul Calabresi. (1966). Use of Allopurinol for Prevention and Control of Hyperuricemia in Patients with Neoplastic Disease. New England Journal of Medicine. 274(9). 481–486. 95 indexed citations

17.

Creasey, William A., et al.. (1963). Clinical and pharmacological studies with 2',3',5'-triacetyl-6-azauridine.. PubMed. 23. 444–53. 57 indexed citations

18.

Calabresi, Paul. (1963). CURRENT STATUS OF CLINICAL INVESTIGATIONS WITH 6-AZAURIDINE, 5-IODO-2'-DEOXYURIDINE, AND RELATED DERIVATIVES.. PubMed. 23. 1260–7. 44 indexed citations

19.

Calabresi, Paul, et al.. (1962). Pharmacological and clinical studies with triacetyl 6-azauridine.. PubMed. 16. 267–9. 6 indexed citations

20.

Beck, Lloyd, Lawrence Kruger, & Paul Calabresi. (1954). OBSERVATIONS ON OLFACTORY INTENSITY. I. TRAINING PROCEDURE, METHODS, AND DATA FOR TWO ALIPHATIC HOMOLOGOUS SERIES. Annals of the New York Academy of Sciences. 58(2). 225–238. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact